Opus Genetics, Inc. — Investor Relations & Filings
Filings indexed
978
across all filing types
Latest filing
2026-04-24
Regulatory Filings
Country
US
United States of America
Listing
US
IRD
Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company that develops gene therapies to treat inherited retinal diseases (IRDs) and other retinal disorders. The company focuses on advancing treatments that address genetic mutations causing vision loss. Its pipeline targets conditions such as Leber congenital amaurosis (LCA), bestrophinopathy (Best disease), and retinitis pigmentosa (RP). The company's primary mission is to restore vision and prevent blindness by creating an efficient path to bring new therapies to the clinic for patients with inherited blinding conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-24 | English | |
| 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-22 | English | |
| 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-07 | English | |
| 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | |
| 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | |
| 8-K - OPUS GENETICS, INC. (0001228627) (Filer) | 2026-02-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36294315 | 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-24 | English | ||
| 35205472 | 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-22 | English | ||
| 33703027 | 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-07 | English | ||
| 32979245 | 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | ||
| 32979139 | 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | ||
| 32889041 | 8-K - OPUS GENETICS, INC. (0001228627) (Filer) | 2026-02-19 | English | ||
| 32889040 | 4 - OPUS GENETICS, INC. (0001228627) (Filer) | 2026-02-17 | English | ||
| 28479870 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 28480001 | 4 Filing | 2026-01-26 | English | ||
| 28479961 | 4 Filing | 2026-01-26 | English | ||
| 28479923 | 4 Filing | 2026-01-26 | English | ||
| 28479847 | 4 Filing | 2026-01-26 | English | ||
| 28479839 | 4 Filing | 2026-01-26 | English | ||
| 28479790 | 4 Filing | 2026-01-26 | English | ||
| 28479892 | S-8 Filing | 2026-01-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
Opus Genetics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34149/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34149 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34149 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34149 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34149}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Opus Genetics, Inc. (id: 34149)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.